AS01 - Allergy and Airway Abstract Publication CHESTglobal-2020_ePoster.mp3

BASELINE CHARACTERISTICS FROM A PHASE 3, RANDOMIZED CONTROLLED TRIAL (COUGH-2) OF GEFAPIXANT, A P2X3 RECEPTOR ANTAGONIST, IN REFRACTORY OR UNEXPLAINED CHRONIC COUGH

Session Name
AS01 - Allergy and Airway
Presentation Type
Abstract Submission
ePoster Audio MP3

Previous ePoster
THE ASTHMA – OBSTRUCTIVE SLEEP APNOEA CO-EXISTENCE DECREASES HIGH DENSITY LIPOPROTEIN CHOLESTEROL, BUT HAS NO SIGNIFICANT EFFECT ON TRIGLYCERIDES AND LOW DENSITY LIPOPROTEIN CHOLESTEROL

Next ePosters
ANGIOTENSIN- (1-7) INDUCES RESOLUTION OF INFLAMMATION AND PROTECTS LUNG TISSUE FROM NEW INFLAMMATORY STIMULI.
HAVING TO TREAT ASTHMA WITHOUT INHALED CORTICOSTEROIDS (OR A CUSHING SYNDROME CASE DUE TO INHALED CORTICOSTEROIDS)
REAL-LIFE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA WITH BENRALIZUMAB
EPINEPHRINE CAUSES SEVERE LACTIC ACIDOSIS IN A PATIENT WITH SHELLFISH INDUCED ANAPHYLAXIS
LUNG MASS AND HEMOPTYSIS IN AN ELDERLY MAN WITH CONTROLLED ASTHMA
RESET OF PERINUCLEAR ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES (P-ANCA) IN PATIENT WITH SEVERE ASTHMA AND EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) DURING BENRALIZUMAB TREATMENT
ABPA IN SEVERE ASTHMA: EFFECT OF TREATMENT IN PATIENTS WITH ACUTE AND WITH EXACERBATED DISEASE
UNUSUAL CAUSE OF RECURRENT BRONCHOSPASM – PLASTIC BRONCHITIS IN AN ADULT FEMALE.
SEVERE BRONCHIAL ASTHMA OR UNCONTROLLED COURSE OF THE DISEASE
THE ROLE OF RADIOGENOMICS IN EGFR AND KRAS MUTATION STATUS PREDICTION AMONG NON-SMALL CELL LUNG CANCER PATIENTS